-
1 Comment
Sumitomo Dainippon Pharma Co., Ltd is currently in a long term uptrend where the price is trading 41.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Sumitomo Dainippon Pharma Co., Ltd's total revenue rose by 5.4% to $133B since the same quarter in the previous year.
Its net income has increased by 141.5% to $33B since the same quarter in the previous year.
Finally, its free cash flow grew by 2252.5% to $80B since the same quarter in the previous year.
Based on the above factors, Sumitomo Dainippon Pharma Co., Ltd gets an overall score of 5/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Exchange | F |
| CurrencyCode | EUR |
| ISIN | JP3495000006 |
| Sector | Healthcare |
| Market Cap | 2B |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.54 |
| Dividend Yield | None |
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. It has partnerships with Keio University; RIKEN; Kyoto University; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for DPM.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
